Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria (Q46068914)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria |
scientific article |
Statements
1 reference
Comparison of ticagrelor, the first reversible oral P2Y(12) receptor antagonist, with clopidogrel in patients with acute coronary syndromes: Rationale, design, and baseline characteristics of the PLATelet inhibition and patient Outcomes (PLATO) tria (English)
1 reference
1 reference
1 reference
Lars Wallentin
1 reference
Robert Harrington
1 reference
Håkan Emanuelsson
1 reference
Christopher P Cannon
1 reference
Hugo Katus
1 reference
Richard Becker
1 reference
Stefan James
1 reference
Steen Husted
1 reference
Axel Akerblom
1 reference
Allan Skene
1 reference
1 April 2009
1 reference
157
1 reference
4
1 reference
599-605
1 reference